Organisations can apply for a share of £20 million, inclusive of VAT, to develop a deployable prototype of an enabling component or sub-system for commercial quantum networking.

UK registered organisations can apply for a share of up to £25 million to develop secure, sustainable or sovereign connectivity technologies that support the UK’s Advanced Connectivity Technologies programme.

£20 million available across two strands to accelerate pharmaceutical, MedTech and digital interventions that improve treatment, recovery and reduce harm and deaths from drug and alcohol addictions. Projects must reach TRL 8 or 9 and progress towards regulatory approval and UK rollout.

Organisations can apply for contracts between £200,000 and £1.5 million (inclusive of VAT) to advance pharmaceutical, MedTech and digital health interventions that improve treatment, recovery and prevention of harm and deaths from drug and alcohol addictions.

UK registered SME businesses can apply for a share of up to £3 million to deliver feasibility studies for frontier artificial intelligence (AI), and machine learning (ML) technologies with a clear route defensible scale-up. This is funded by Innovate UK.

UK registered micro, small or medium sized enterprises (SMEs) can apply for a share of up to £2 million for pre-commercialisation projects.

Up to £2 million, inclusive of VAT, is available for Phase 1 feasibility projects developing disruptive alternatives to animal use in pharmacokinetic and cardiovascular safety studies.

UK registered organisations can apply for a share of up to £3 million from Innovate UK to deliver innovative quantum technology projects in collaboration with German partners.

For farming, growing and forestry businesses in England to test and demonstrate innovative ideas that boost productivity, resilience and sustainable, net zero farming.

UK registered organisations can apply for a share of up to £18.5 million to integrate UK anchored advanced connectivity components at a system level into technically assured, end to end architectures ready for early market evaluation.